Family Medicine Doctors in Charleroi, PA Accepting Medicare
7 Family Medicine doctors found. Showing 1 - 7
 Dr. Scott Daniel Seifert, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 17 Arentzen Blvd Ste 101, Charleroi, PA 15022 Phone: 724-483-3581 Fax: 724-483-3483 |
 Rhonda Lynn Wingrove, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17 Arentzen Blvd, Charleroi, PA 15022 Phone: 724-483-3581 Fax: 724-483-3483 |
Umberto Anthony Derienzo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17 Arentzen Blvd, Charleroi, PA 15022 Phone: 724-483-3581 Fax: 724-483-3483 |
Dr. Edward Salopek, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Mckean Ave, Charleroi, PA 15022 Phone: 724-483-5482 |
Mohammad F Pathan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Mckian Ave, Charleroi, PA 15022 Phone: 724-483-8065 Fax: 724-565-5110 |
Dr. Shaunaq Parikh, DO Family Medicine - Adult Medicine Medicare: Medicare Enrolled Practice Location: 1200 Mckean Ave, Charleroi, PA 15022 Phone: 724-483-6600 |
Dr. Robert L Belluso, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Chamber Plz, Charleroi, PA 15022 Phone: 724-483-5482 Fax: 724-483-5856 |
News Archive
Compounds break bonds holding dangerous pollutants together
Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.
Ahram Biosystems launches cost-effective, high-performance portable PCR system
Ahram Biosystems, Inc., a leading innovator of new life science tools, today announced the launch of Palm PCR F1-12, the economy model of its innovative portable PCR system. The F1-12 system is a cost-effective, high-performance portable PCR system, delivering PCR amplification with high speed and sensitivity in a fully portable format.
Progeria-derived iPS cells may treat aging-related disease in children
The current pace of population aging is without parallel in human history but surprisingly little is known about the human aging process, because lifespans of eight decades or more make it difficult to study. Now, researchers at the Salk Institute for Biological Studies have replicated premature aging in the lab, allowing them to study aging-related disease in a dish.
Oncolytics announces completion of patient enrollment in REOLYSIN Phase II colorectal cancer study
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer (IND 210). The trial is being sponsored and conducted by the NCIC Clinical Trials Group at Queen's University in Kingston, Ontario.
› Verified 4 days ago
Family Medicine
Internal Medicine
Ophthalmology
Pediatrics
Gastroenterology
Nephrology
Allergy & Immunology